Skip to content

Study · Measured the body's own peptide · 1994

1 result

Amplification-independent overexpression of thymosin beta-10 mRNA in human renal cell carcinoma.

Hall AK

Renal failure1 Jan 1994Cited by 10 (Europe PMC)

PMID8041963 (opens in a new tab)DOI10.3109/08860229409044864 (opens in a new tab)PepBankPUB-08041963
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In human kidney tissue, thymosin beta‑4 protein was decreased in normal adult kidney, and this matched a decrease in its mRNA levels.

    In plain wordsIn human kidney tissue, the body's own thymosin beta‑4 protein was lower in normal adult kidney, matching lower mRNA levels.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    DecreaseThymosin beta-4 protein and mRNA in normal adult kidney
    Study

    n: not reported in source

    Outcome group
    Gene expression · Kidney and urinary

    Source sentences

    Summary
    Decreased expression of both the thymosin beta-4 and beta-10 proteins in the normal adult human kidney was found to be derived from a corresponding decrease in levels of the cognate mRNAs.
    1 context sentence
    Summary · context
    The present study used a human thymosin beta-10 cDNA to examine the possibility that overexpression of the beta-10 mRNA in renal cell carcinoma was due to gene amplification.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.